logo

BSTZ

BlackRock Science·NYSE
--
--(--)
--
--(--)
3.52 / 10
Netural

Fundamental quality scores 3.5/10, indicating concerns. Inventory turnover days (210.8) and ratio (106.6) are strong, but diluted EPS YoY growth (31.1%) and current assets/total assets (46.6%) are weak. Overall, fundamentals are guarded.

Fundamental(3.52)SentimentTechnical

Analysis Checks(7/9)

Inventory turnover ratio
Value106.57
Score2/3
Weight9.98%
1M Return1.46%
Gross profit margin (%)
Value48.34
Score2/3
Weight10.08%
1M Return1.44%
Accounts receivable turnover ratio
Value23.61
Score2/3
Weight13.85%
1M Return2.07%
Rate of return on total assets (%)
Value-7.83
Score2/3
Weight10.01%
1M Return1.48%
Fixed assets turnover ratio
Value9771.06
Score3/3
Weight19.49%
1M Return2.73%
Annualized return on total assets (%)
Value-7.83
Score2/3
Weight10.01%
1M Return1.48%
Diluted earnings per share (YoY growth rate %)
Value31.14
Score0/3
Weight6.21%
1M Return0.90%
Inventory turnover days
Value210.83
Score3/3
Weight10.16%
1M Return1.49%
Current assets / Total assets (%)
Value46.64
Score1/3
Weight10.20%
1M Return1.45%
Is BSTZ undervalued or overvalued?
  • BSTZ scores 3.52/10 on fundamentals and holds a Fair valuation at present. Backed by its 18.54% ROE, 9830.58% net margin, 4.96 P/E ratio, 0.91 P/B ratio, and 22.20% earnings growth, these metrics solidify its Netural investment rating.